International Biotechnology Trust PLC Paratek Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $496,800 - $1.2 Million	-103,500 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $85,975 - $104,025	-9,500 Reduced 8.41%	103,500 $766,000
Q3 2018 Nov 13, 2018	BUY	$9.05 - $10.95 $85,975 - $104,025	9,500 Added 9.18%	113,000 $1.46 Million
Q1 2018 May 15, 2018	SELL	$12.65 - $18.85 $1.9 Million - $2.83 Million	-150,000 Reduced 59.17%	103,500 $1.35 Million
Q4 2017 Mar 02, 2018	BUY	$17.45 - $25.6 $898,675 - $1.32 Million	51,500 Added 25.5%	253,500 $4.54 Million
Q3 2017 Mar 02, 2018	BUY	$18.9 - $28.2 $2.72 Million - $4.06 Million	144,000 Added 248.28%	202,000 $5.07 Million
Q2 2017 Mar 02, 2018	BUY	N/A	58,000	58,000 $1.4 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.